Insights

ISCTM and ECNP | Posters & Presentations

ISCTM and ECNP | Posters & Presentations Amsterdam, Netherlands | ISCTM: 9-11th October | ECNP: 11-14th October We’re excited to announce that our team will be attending the ISCTM 2025 Autumn Conference and ECNP 38th Congress 2025 This year’s program features world-class discussions on precision psychiatry, psychedelic therapies, and lessons from global clinical trials—and we’re proud to be […]

ISCTM and ECNP | Posters & Presentations Read More »

How Picture Description Tasks Can Help Track Cognitive Health Remotely

How Picture Description Tasks Can Help Track Cognitive Health Remotely Speech as a digital biomarker in clinical research Changes in how we speak—how quickly we talk, how often we pause, and the words we choose—can be early signs of cognitive decline. People with mild cognitive impairment (MCI) or dementia due to Alzheimer’s disease (AD) often

How Picture Description Tasks Can Help Track Cognitive Health Remotely Read More »

Cognition in The Blood (Biomarker)

Cognition in The Blood (Biomarker) How do digital cognitive assessments relate to the Blood Plasma p-Tau217 in patients with Mild Cognitive Impairment (MCI)? Our latest research explores an exciting dataset with the AI–Mind Project, who have given us the opportunity to test the associations of our cognitive assessments alongside classic paper-and-pencil tests to levels of

Cognition in The Blood (Biomarker) Read More »

SIRS 2025: Insights on Schizophrenia Research, From Rights Based Care to Digital Biomarkers

SIRS 2025: Insights on Schizophrenia Research, From Rights Based Care to Digital Biomarkers Michael Spilka, Sr. Clinical Scientist This year’s Schizophrenia International Research Society (SIRS) 2025 Congress in Chicago brought together leading scientists and researchers, exploring the latest advancements and ongoing challenges in understanding and addressing schizophrenia. Michael Spilka, PhD. shares his key insights from

SIRS 2025: Insights on Schizophrenia Research, From Rights Based Care to Digital Biomarkers Read More »

Dementias Platform UK: TRANSLATIONS 2025

Dementias Platform UK: TRANSLATION 2025 Martina De Lillo, Clinical Scientist We recently attended TRANSLATION 2025, organized by Dementia Platform UK, where experts shared groundbreaking developments in treatment approaches, diagnostic methods, and research methodologies. The presentations revealed a field undergoing rapid transformation, with significant implications for patients and healthcare professionals alike. The theme of the conference

Dementias Platform UK: TRANSLATIONS 2025 Read More »

When to Use Standardised Assessments—And When You Might Need to Build Your Own

When to Use Standardised Assessments—And When You Might Need to Build Your Own Alex Kaula, Senior R&D Scientist Hello, I’m Alex Kaula, Senior R&D Scientist at Cambridge Cognition. If your research involves measuring cognitive function or clinical outcomes, you’ve likely faced this question: Should I use an established, validated assessment, or create a new one

When to Use Standardised Assessments—And When You Might Need to Build Your Own Read More »

Actigraphy and wearable sensor technologies to enhance assessment in health conditions

Actigraphy and wearable sensor technologies to enhance assessment in health conditions affecting motor function and behaviour Reflections from the 2025 Actigraph Digital Data Summit​ The 2025 ActiGraph Digital Data Summit in Pensacola, FL, provided a valuable environment for exploring the benefits and challenges of using actigraphy, and other wearable sensor technologies, to enhance assessment in

Actigraphy and wearable sensor technologies to enhance assessment in health conditions Read More »

Scroll to Top